Secondary Logo

Journal Logo

October 2013 - Volume 34 - Issue 10
pp: 935-1032

Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment

González-Barca, Eva; Canales, Miguel; Cortés, Montse; More

Nuclear Medicine Communications. 34(10):946-952, October 2013.

UK audit of quantification of left-ventricular function using gated myocardial perfusion imaging

Cade, Sarah C.; Hall, David O.; Kenny, Bob; More

Nuclear Medicine Communications. 34(10):990-1004, October 2013.